Page 51 - sprouting/2025autumn

校園動態 CAMPUS

藥物發現專家躋身全球前 1%
DRUG DISCOVERY EXPERT AMONG

THE WORLD’S TOP 1%

科睿唯安每年評選“全球高被引科 Clarivate’s Highly Cited Researchers list recognises scholars
學家”，表彰在過去發表多篇高被 who have published multiple highly cited papers over the past
引論文且在 Web of Science 核心合 11 years, ranking in the top 1% by citations within their field in
集同領域中名列前 1% 的學者。應用 the Web of Science Core Collection. In 2025, Professor Yao
科學學院姚小軍教授榮登“跨學科 Xiaojun at the Faculty of Applied Sciences, was named in the
領域”榜單，成為澳門五位獲此榮 Cross-Field category, joining five distinguished scholars from
譽的學者之一。姚教授在人工智能 Macao in receiving this honour. Professor Yao is a leading
藥物發現、分子模擬、抗腫瘤候選 figure in AI-driven drug discovery, molecular simulation, and
藥物研究等領域成果斐然，發表國 anticancer drug research. He has published over 160 papers in
際頂尖期刊論文超過 160 篇，累計 top-tier international journals, with more than 22,000 citations.
引用次數超過 22,000 次，並主持多 He has also led numerous major research projects funded by
項國家自然科學基金及澳門科學技 China’s National Natural Science Foundation and the Macao
術發展基金重大課題，推動人工智 Science and Technology Development Fund, driving innovation
能與生物醫藥交叉領域的創新發展。 at the intersection of artificial intelligence and biomedicine.

科研實力與國際影響力持續提升

ADVANCING RESEARCH EXCELLENCE AND
GLOBAL IMPACT

澳理大學者能夠躋身全球頂尖科學 The inclusion of MPU scholars in these prestigious global
家行列，體現大學科研質量、學科 rankings highlights the University’s sustained progress in
建設與創新能力持續提升，為粵港 research quality, academic development, and innovation.
澳大灣區科技發展與高層次人才培 It also reinforces MPU’s role in supporting technological
育提供堅實支撐。未來，澳理大將 advancement and talent cultivation in the Guangdong-
繼續推動跨學科研究，深化國際合 Hong Kong-Macao Greater Bay Area. Looking ahead, MPU
作，致力於打造具有全球競爭力的 will continue to foster interdisciplinary research, strengthen
科研平台。 international collaboration, and build world-class research
platforms with global competitiveness.

49